KPTI
Karyopharm Therapeutics Inc
Price:  
1.18 
USD
Volume:  
1,701,214.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KPTI WACC - Weighted Average Cost of Capital

The WACC of Karyopharm Therapeutics Inc (KPTI) is 7.4%.

The Cost of Equity of Karyopharm Therapeutics Inc (KPTI) is 12.65%.
The Cost of Debt of Karyopharm Therapeutics Inc (KPTI) is 5.00%.

Range Selected
Cost of equity 8.40% - 16.90% 12.65%
Tax rate 0.10% - 0.20% 0.15%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.1% - 8.7% 7.4%
WACC

KPTI WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.99 2.15
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.40% 16.90%
Tax rate 0.10% 0.20%
Debt/Equity ratio 2.23 2.23
Cost of debt 5.00% 5.00%
After-tax WACC 6.1% 8.7%
Selected WACC 7.4%